MedPath

Comparative Evaluation of Diffusion Weighted MRI And Ultrasonography In The Detection of Breast Lesions

Active, not recruiting
Conditions
Breast LN
Registration Number
NCT06744101
Lead Sponsor
Superior University
Brief Summary

This study aims to conduct a comparative evaluation of Diffusion Weighted MRI (DW-MRI) and Ultrasonography (US) in detecting breast lesions. Breast cancer remains a leading cause of cancer-related deaths among women worldwide, necessitating efficient and accurate diagnostic methods. Ultrasonography, a commonly used imaging modality, provides valuable insights into breast lesions but has limitations in sensitivity and specificity.

Detailed Description

Diffusion Weighted MRI, on the other hand, shows potential for higher accuracy in identifying malignant versus benign lesions due to its ability to assess tissue cellularity and integrity non-invasively. This research will involve a specified number of female participants within a defined age range, focusing on the comparative effectiveness, sensitivity, and specificity of DW-MRI and US. The findings are expected to contribute valuable insights into optimizing breast cancer diagnostic protocols, ultimately aiding in earlier detection, better patient outcomes, and possibly reducing the need for invasive biopsy procedures.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
108
Inclusion Criteria
  • Women with suspected breast lesions
  • Breast feeding woman
  • Referred for MRI examination.
  • Age 18 years or older
  • Ability to provide informed consent.
Exclusion Criteria
  • Contraindications to MRI or contrast agent
  • Previous breast Implant
  • Early Pregnancy

Exclusion criteria

*

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and Specificity12 Months

* Ultrasonography (USG): BI-RADS classification.

* Diffusion Weighted MRI (DWI): Apparent Diffusion Coefficient (ADC) values.

* Scales/Measurements:

* Sensitivity (%):

Formula: (True Positives) ÷ (True Positives + False Negatives) × 100

* Specificity (%):

Formula: (True Negatives) ÷ (True Negatives + False Positives) × 100

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

563-B peoples colony 1 main satiana road Faisalabad

🇵🇰

Faisalābad, Punjab, Pakistan

© Copyright 2025. All Rights Reserved by MedPath